Invitae partners with KEW, Inc. to develop somatic mutation detection capabilities to improve cancer care by providing comprehensive genomic information

March 16, 2018

Responsive image

SAN FRANCISCO, and CAMBRIDGE, Mass., March 16, 2018 /PRNewswire/ — Invitae Corporation (NYSE: NVTA) and KEW, Inc. today announced a collaboration to develop comprehensive genomic profiling solutions for sequencing tumor DNA on Invitae’s next generation sequencing (NGS) platform. By…

Category: Precious Metals